WHO Announces 3 New Drugs For COVID-19 Clinical Trials

Related stories

“Stay Away from National Assembly,” Senate warns Natasha

By Abiola Olawale The Nigerian Senate has issued a s...

Awujale’s burial and Aso Rock’s graveyard politics By Festus Adedayo

By Festus Adedayo “Why should I bother myself with what...

Three deaths: Gainers and losers By Bolanle BOLAWOLE

By Bolanle BOLAWOLE turnpot@gmail.com 0705 263 1058. The death of three...

(VIDEO) Applause as Billionaire Business Icon, Leemon Ikpea’s State-of-the-art Medical Facility in Ewatto, Nears Completion 

https://m.youtube.com/watch?v=UCKl8rwMdSM&t=12s By Abiola Olawale The people of Ewatto in Esan South...

Before you accept his proposal, By Funke Egbemode

By Funke Egbemode If the man you are considering spending...

Three new candidate drugs are being tested in the latest phase of global Solidarity clinical trials to find effective treatments against COVID-19, the World Health Organisation (WHO) announced on Wednesday.

The therapies — artesunate, imatinib, and infliximab — will be tested on hospitalised COVID-19 patients in 52 countries under the Solidarity PLUS programme.

There have been more than 203 million cases of the disease recorded globally as of Wednesday, according to WHO.

The world hit the 200 million mark last week, just six months after cases passed 100 million.

Speaking during a press conference in Geneva, WHO’s Director-General, Dr. Tedros Ghebreyesus underscored the critical need to find more effective and accessible COVID-19 therapeutics.

“We already have many tools to prevent, test for, and treat COVID-19, including oxygen, dexamethasone, and IL-6 blockers.

“But we need more, for patients at all ends of the clinical spectrum, from mild to severe disease. And we need health workers that are trained to use them in a safe environment,” he said.

The three drugs were selected by an independent panel for their potential in reducing the risk of death in people hospitalised for COVID-19.

They are already being used to treat other conditions.

Artesunate is a medicine for severe malaria, imatinib is used for certain cancers, including leukemia, while infliximab is used to treat Crohn’s Disease, rheumatoid arthritis, and other diseases of the immune system.

Manufacturers Ipca, Novartis, and Johnson & Johnson donated the drugs for the trial.

Solidarity PLUS is the largest global collaboration among WHO’s 194 Member States, with thousands of researchers in over 600 hospitals participating.

Finland is among the 52 countries taking part, 16 more than the initial Solidarity Trial, and contributes to the COVAX vaccine solidarity initiative. Two university hospitals in Finland have been the first worldwide to begin the second phase.

Hanna Sarkkinen, the country’s Minister of Social Affairs and Health, said clinical trials had a great potential to save lives.

“Even though there are approximately 3,000 clinical studies on COVID-19, most of them are too small to yield significant information. We need clinical trials that are large enough to bring better treatments for COVID-19 patients,” she said.

Four drugs were evaluated under the initial Solidarity Trial in 2020, which showed that remdesivir, hydroxychloroquine, lopinavir, and interferon had little or no effect on hospitalised patients with Covid-19.

NAN

Hamilton Nwosa
Hamilton Nwosa
Hamilton Nwosa is an experienced, and committed communication, business, administrative, data and research specialist . His deep knowledge of the intersection between communication, business, data, and journalism are quite profound. His passion for professional excellence remains the guiding principle of his work, and in the course of his career spanning sectors such as administration, tourism, business management, communication and journalism, Hamilton has won key awards. He is a delightful writer, researcher and data analyst. He loves team-work, problem-solving, organizational management, communication strategy, and enjoys travelling. He can be reached at: hamilton_68@yahoo.com

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories

NDN
Latest News
"Stay Away from National Assembly," Senate warns NatashaAwujale’s burial and Aso Rock’s graveyard politics By Festus AdedayoThree deaths: Gainers and losers By Bolanle BOLAWOLE(VIDEO) Applause as Billionaire Business Icon, Leemon Ikpea's State-of-the-art Medical Facility in Ewatto, Nears Completion Before you accept his proposal, By Funke EgbemodeOil Price Volatility and Higher Valuations Cause M&A Activity to SlowDrama as UNIMAID ASUU Opposes Tinubu, Vows To Contest Renaming of Varsity After Late BuhariFalana Lashes Okpebholo, Warns: "Withdraw Your Statement, Apologize to Obi immediately."NDDC's N6 trillion: SERAP Drags Tinubu to Court Over Non-Release of Forensic Audit ReportFears Soars As PDP Confirms Assassination Attempt on Anambra Gov Candidate, EzenwaforBreakdown as FAAC Disburses N1.818 Trillion in June 2025 2027: Osun Senator, Fadeyi Dumps PDP, Amid Adeleke's Defection SpeculationsRanked: The 40 Countries With the Best Culture and HeritageEFCC Probing 18 Sitting Governors in Major Corruption Crackdown, Olukoyede RevealsNatasha Vows to Return to Senate Tuesday, Despite Akpabio's Appeal
X whatsapp